NovaBay Pharma's total assets for Q3 2024 were $3.88M, a decrease of -1.22% from the previous quarter. NBY total liabilities were $2.81M for the fiscal quarter, a -38.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.